IssuerAnnouncementDetailsV2Portlet

Actions

Morabaha Marina Financing Co. Announces the Results of the Ordinary General Assembly Meeting, ( First Meeting )

4082
MRNA
0.36 %
1445/10/14     23/04/2024 08:15:25

Element ListExplanation
Introduction Morabaha Marina Financing Company (“mrna”) is pleased to announce the results of the Ordinary General Assembly Meeting (First Meeting).
City and Location of the General Assembly's Meeting At the Company's headquarters in Riyadh – Al-Rabie District, through means of modern technology (remotely)
Date of the General Assembly's Meeting 2024-04-22 Corresponding to 1445-10-13
Time of the General Assembly’s Meeting 19:30
Percentage of Attending Shareholders 36.9%
Names of the Board of Directors' Members Present at the General Assembly's Meeting and Names of the Absentees The following board members attended the meeting with their names:

1. Mr. Abdulrahman Mohammed Alghimlas - Chairman

2. Mr. Khalid Mohammed Alonaizan - Vice-Chairman

3. Mr. Abdullah Mohammed Alrayes - Managing Director

4. Mr. Fehaid Mazi Alosaimi - Board Member

5. Mr. Saad Abdulaziz Alhoshan - Board Member

6. Mr. Naif Talal Almaiman - Board Member

Names of the Board Members who apologized attending the meeting:

1. Mr. Waleed Yousef Alghamlas - Board Member

2. Mr. Ibrahim Abdullah Alghemlas - Board Member

Names of the Chairmen of the Committees Present at the General Assembly's Meeting or Members of such Committees Attending on Their Behalf 1. Mr. Khalid Mohammed Alonaizan - Remuneration & Nomination Committee Chairman – Credit and Risk Committee Chairman

2. Dr. Nasser Mohammed Alsadoun - Audit Committee Chairman

3. Mr. Abdullah Mohammed Alrayes - Executive Committee Chairman

Voting Results on the Items of the General Assembly's Meeting Agenda's 1. The annual report of the Board of Directors for the financial year ending on December 31, 2023 was reviewed and discussed.

2. The company’s financial statements for the fiscal year ending on December 31, 2023 were reviewed and discussed.

3. Approval on the auditor's report for the fiscal year ending on 31 December 2023 after discussing it.

4. Approval on appointing the auditor for the Company from among the candidates based on the Audit Committee's recommendation. namely Ernst & Young, The appointed auditor shall examine, review and audit the second, third, and annual financial statements, of the fiscal year 2024 and the determination of the auditor's remuneration.

5. Approval on the discharge of the members of the Board of Directors during the financial year ended 31 December 2023.

6. Approval on the amendment of the social responsibility policy.

7. Approval on the Conflict-of-Interest Policy and Business Ethics.

The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.

Company Performance

MRNA
Add To Watchlist
In your Watchlist
Add To Watchlist
Key Parameters
Last Price 11.2
Net Change 0.04 (+0.36%)
Value Traded (Sar) 606,057.24
Volume Traded 54,314
See The Company Profile

LoginPortletPopupv2

Actions

AddtoWatchlistv2

Actions

Add to watchlist